SEMA 3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1-Reference-Cited by-同舟云学术

SEMA 3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1

Published:2018-01-18 Issue:2 Volume:10 Page:219-238
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Peacock James W¹²,Takeuchi Ario¹³,Hayashi Norihiro¹⁴,Liu Liangliang¹,Tam Kevin J¹²,Al Nakouzi Nader¹,Khazamipour Nastaran¹,Tombe Tabitha¹,Dejima Takashi¹³,Lee Kevin CK¹,Shiota Masaki¹³,Thaper Daksh¹²,Lee Wilson CW¹,Hui Daniel HF¹,Kuruma Hidetoshi¹,Ivanova Larissa¹,Yenki Parvin¹²,Jiao Ivy ZF¹,Khosravi Shahram¹,Mui Alice L‐F⁵,Fazli Ladan¹,Zoubeidi Amina¹²,Daugaard Mads¹²,Gleave Martin E¹²^ORCID,Ong Christopher J¹²^ORCID

Affiliation:

1. Vancouver Prostate Centre Vancouver BC Canada

2. Department of Urologic Sciences University of British Columbia Vancouver BC Canada

3. Department of Urology Graduate School of Medical Sciences Kyushi University Fukuoka Japan

4. Department of Urology The Jikei University School of Medicine Tokyo Japan

5. Department of Surgery University of British Columbia Vancouver BC Canada

Funder

Terry Fox Foundation

Prostate Cancer Foundation

Prostate Cancer Canada

Canadian Cancer Society Research Institute

National Institutes of Health